Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yihuohuatan Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed by the West China Hospital of Sichuan University for the treatment of stable chronic obstructive pulmonary disease (COPD). The name "Yihuo Huatan" translates to "tonifying fire and resolving phlegm," reflecting its therapeutic approach of addressing underlying deficiencies (often Kidney Yang) while clearing pathological phlegm accumulation. It is typically administered as an oral decoction. Clinical evaluation, such as trial ChiCTR2100051149, focuses on its efficacy in improving lung function, reducing exacerbation frequency, and enhancing the quality of life in COPD patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yihuohuatan Decoction (West China Hospital of Sichuan University).